A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Best Biotech Stocks To Watch Now – March 12th
AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Buy at StockNews.com
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a ...
MoneyWeek on MSN6d
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success ...
pharmaphorum2d
Vertex gets EU okay to treat younger cystic fibrosis patients
The next phase of Vertex is focused on the roll-out of its new triple Kaftrio (tezacaftor, ivacaftor and elexacaftor), which was launched last year in the US (as Trikafta) and was approved by the ...
pharmaphorum1d
FDA approves flurry of drugs ahead of holiday season
It is also dosed just once a day, while Trikafta needs twice-daily dosing. The task ahead of Vertex now is to migrate patients already on Trikafta to the new drug. That is supported by data from ...
Precision Medicine Online6d
UK's MHRA Approves Vertex's Cystic Fibrosis Drug Alyftrek
The agency approved it based on two Phase III studies showing the drug to be as effective as another combination therapy at improving lung function.